DNMT3A and acute myeloid leukemia: These data are consistent with accelerated leukemia development in miR196b–/–Dnmt3a+/–Flt3ITD compared to Dnmt3a+/-Flt3ITD mice, which was maintained upon transplantation of equal numbers of AML cells into normal healthy secondary recipient mice (Fig. 1H).